ArticleFrontiers in endocrinology2025
The interplay between metabolic health factors and stroke incidence in aging populations.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Association between insulin resistance surrogate markers and cardiovascular disease risk in individuals with subclinical metabolic disorders: a prospective cohort study based on baseline levels, cumulative exposure, and longitudinal trajectories.Cardiovascular diabetology · 2026Article
- Novel lipid and obesity indices with new-onset stroke among adults aged 50 years and older in England.Scientific reports · 2026Article
- Preoperative total cholesterol and axillary lymph node burden in breast cancer: an exploratory analysis with a preliminary nomogram.Frontiers in surgery · 2026Article
- The association between the ZJU index and short-term prognosis in patients with acute ischemic stroke: a cohort study.Frontiers in endocrinology · 2026Article
Corrections and comments
- Erratum issued
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Stroke remains a leading cause of morbidity and mortality in aging populations, and its risk is closely linked to metabolic disorders such as diabetes, hypertension, hyperlipidemia, and obesity. To better understand these relationships, this study aimed to quantify the associations between key metabolic health factors and both stroke incidence and cognitive outcomes in older adults, and to evaluate the predictive value of these metabolic factors for stroke risk through cross-sectional secondary analyses of two population-based cohort datasets. Methods: We analyzed data from the Health and Retirement Study (HRS; n = 7,322) and the English Longitudinal Study of Ageing (ELSA; n = 6,630). Associations with stroke incidence were assessed using multivariable logistic regression, and associations with cognitive outcomes were examined using multivariable linear regression. Random forest models evaluated the relative importance of metabolic factors for stroke prediction, with discrimination quantified by ROC curves (AUC). Mediation analyses explored whether stroke mediated the link between metabolic disorders and cognition. Results: Across both cohorts, diabetes and hypertension were consistently associated with higher odds of stroke, while obesity and hyperlipidemia showed smaller and cohort-dependent associations. Random forest analyses identified hypertension and diabetes as the strongest predictors of stroke. ROC analyses showed moderate discriminative performance for single metabolic factors (AUCs generally 0.70 - 0.80), with obesity performing weakest. Metabolic disorders-particularly diabetes and hypertension-were associated with worse cognitive performance, whereas hyperlipidemia showed small positive associations with certain cognitive measures in some models. Mediation analyses suggested that part of the adverse impact of metabolic disorders on cognition operates through stroke. Conclusions: Metabolic health is strongly linked to stroke risk and cognitive outcomes in older adults. Targeted detection and management of hypertension and diabetes should be prioritized to reduce stroke burden and cognitive decline. Given only moderate predictive performance of single metabolic markers, comprehensive risk models integrating socioeconomic, clinical, and lifestyle factors are warranted for improved stroke risk stratification.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.